Microbio Statistics

Total Valuation

Microbio has a market cap or net worth of TWD 16.09 billion. The enterprise value is 15.71 billion.

Market Cap	16.09B
Enterprise Value	15.71B

Important Dates

The last earnings date was Friday, March 7, 2025.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Microbio has 588.17 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	588.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	7.43%
Float	428.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.34
PB Ratio	1.56
P/TBV Ratio	1.59
P/FCF Ratio	31.71
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.27
EV / Sales	9.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	30.97

Financial Position

The company has a current ratio of 5.85, with a Debt / Equity ratio of 0.05.

Current Ratio	5.85
Quick Ratio	5.33
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	1.21
Interest Coverage	-44.55

Financial Efficiency

Return on equity (ROE) is -10.08% and return on invested capital (ROIC) is -2.12%.

Return on Equity (ROE)	-10.08%
Return on Assets (ROA)	-1.97%
Return on Invested Capital (ROIC)	-2.12%
Return on Capital Employed (ROCE)	-3.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	4.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.83% in the last 52 weeks. The beta is 1.56, so Microbio's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-35.83%
50-Day Moving Average	31.18
200-Day Moving Average	36.60
Relative Strength Index (RSI)	32.01
Average Volume (20 Days)	1,048,368

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbio had revenue of TWD 1.72 billion and -1.10 billion in losses. Loss per share was -1.87.

Revenue	1.72B
Gross Profit	676.08M
Operating Income	-451.42M
Pretax Income	-1.28B
Net Income	-1.10B
EBITDA	-350.30M
EBIT	-451.42M
Loss Per Share	-1.87

Full Income Statement

Balance Sheet

The company has 2.55 billion in cash and 615.73 million in debt, giving a net cash position of 1.94 billion or 3.29 per share.

Cash & Cash Equivalents	2.55B
Total Debt	615.73M
Net Cash	1.94B
Net Cash Per Share	3.29
Equity (Book Value)	11.87B
Book Value Per Share	17.52
Working Capital	2.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 529.90 million and capital expenditures -22.58 million, giving a free cash flow of 507.32 million.

Operating Cash Flow	529.90M
Capital Expenditures	-22.58M
Free Cash Flow	507.32M
FCF Per Share	0.86

Full Cash Flow Statement

Margins

Gross margin is 39.24%, with operating and profit margins of -26.20% and -63.89%.

Gross Margin	39.24%
Operating Margin	-26.20%
Pretax Margin	-74.20%
Profit Margin	-63.89%
EBITDA Margin	-20.33%
EBIT Margin	-26.20%
FCF Margin	29.45%

Dividends & Yields

Microbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.84%
FCF Yield	3.15%

Dividend Details

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	1.049999998

Scores

Microbio has an Altman Z-Score of 7.02.

Altman Z-Score	7.02
Piotroski F-Score	n/a